Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults

被引：15

作者：

Cidem, Muharrem ^{[1
]}

Karacan, Ilhan ^{[1
]}

Arat, Neval Bozok ^{[1
]}

Zengi, Oguzhan ^{[2
]}

Ozkaya, Murat ^{[1
]}

Guzel, Saadet Pilten ^{[2
]}

Ozkan, Cansu ^{[1
]}

Beytemur, Ozan ^{[3
]}

机构：

[1] Bagcilar Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkey

[2] Bagcilar Training & Res Hosp, Dept Biochem, Istanbul, Turkey

[3] Bagcilar Training & Res Hosp, Orthopaed & Traumatol Dept, Istanbul, Turkey

来源：

RHEUMATOLOGY INTERNATIONAL | 2015年 / 35卷 / 10期

关键词：

Sclerostin; 25-Hydroxyvitamin D; Osteomalacia; BONE; CALCIUM;

D O I：

10.1007/s00296-015-3294-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sclerostin is produced almost exclusively by osteocytes, which also express receptors for 1,25 dihydroxyvitamin D3. The aim of this study was to investigate the effects of vitamin D3 treatment on serum sclerostin levels in young adult females with severe vitamin D deficiency. A total of 26 subjects were treated orally with calcium (1.200 mg/day for 2 months) and vitamin D3 (300.000 IU/week for 1 month). Serum 25-hydroxyvitamin D (25(OH)D) and sclerostin levels were measured before and after treatment. Baseline serum 25(OH)D and sclerostin levels were at 5.7 +/- A 2.4 ng/mL and 39.1 +/- A 14.4 pg/mL, respectively. Serum 25(OH)D was significantly increased, to 62.4 +/- A 18.7 ng/mL, following treatment; serum sclerostin was significantly decreased, to 29.3 +/- A 8.8 pg/mL. We conclude that serum sclerostin level is decreased following vitamin D3 treatment in patients with vitamin D deficiency.

引用

页码：1739 / 1742

页数：4

共 50 条

[31] Abnormal sulfate metabolism in vitamin D-deficient rats
Fernandes, I
Hampson, G
Cahours, X
Morin, P
Coureau, C
Couette, S
Prie, D
Biber, J
Murer, H
Friedlander, G
Silve, C
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09): : 2196 - 2203
[32] Higher serum alkaline phosphatase activity in infants born to vitamin D-deficient mothers
Al Alwan, Ibrahim
Al Badi, Maryam
Badri, Motasim
Tamimi, Waleed
Al Dubayee, Mohamed
Mughal, M. Zulf
Babiker, Amir
ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
[33] IMPROVEMENT IN PANCREATIC β-CELL FUNCTION WITH VITAMIN D AND CALCIUM SUPPLEMENTATION IN VITAMIN D-DEFICIENT NONDIABETIC SUBJECTS
Harinarayan, Chittari Venkata
Arvind, Shalini
Joshi, Shalini
Thennarasu, Kandavel
Vedavyas, Vasanthi
Baindur, Anushka
ENDOCRINE PRACTICE, 2014, 20 (02) : 129 - 138
[34] High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients
Zaidan, Julie
Wang, Xiangbing
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17): : 1669 - 1671
[35] Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients
Dickerson, Roland N.
Turner, Stephen C.
Holmes, Whitney L.
Van Matre, Edward T.
Swanson, Joseph M.
Byerly, Saskya
Filiberto, Dina M.
Fischer, Peter E.
NUTRIENTS, 2022, 14 (08)
[36] MODELLING COGNITIVE SYMPTOMS IN DEVELOPMENTAL VITAMIN D-DEFICIENT RATS
Burne, Thomas H. J.
Turner, Karly
McGrath, John J.
Eyles, Darryl W.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A13 - A14
[37] An unusual case of hyperphosphatemia in a vitamin D-deficient patient with tuberculosis
Lee, Roland H.
Felsenfeld, Arnold J.
Levine, Barton S.
CLINICAL KIDNEY JOURNAL, 2011, 4 (04): : 264 - 269
[38] Serum level of sclerostin and vitamin D in children with epilepsy
Sarhan, Abdalla Al-Ma'moon
Mahmoud, Wael
Aldarah, Munayr Jabullah
Hashim, Noha A.
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
[39] Oral glucose tolerance is unaltered in vitamin D-deficient rat
Ayesha, I
Raghuramulu, N
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2000, 46 (03) : 115 - 118
[40] How should we manage vitamin D-deficient adolescents?
Atabek, Mehmet Emre
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (9-10): : 1009 - 1010

← 1 2 3 4 5 →